DR. THOMAS A. WEST, MD, FACS

Plain English
This study looked at how often venous air embolism (VAE) happens during brain surgery performed with patients lying down, particularly those undergoing tumor removal. Researchers examined the records of over 3,500 patients and found 14 confirmed cases of VAE and 86 suspected cases based on changes in a specific breathing measurement. The findings highlight that many VAE events occurred even when specialized monitoring was not in place, which suggests a need for better pre-surgery identification of patients at risk. Who this helps: This benefits surgeons and medical teams by improving patient safety during brain surgery.

Plain English
This study looked at bacterial meningitis cases in Southern Sweden between 2013 and 2023 to see how common it is and which germs are causing it. They found 244 cases affecting 238 people, with a decreasing rate of 1.63 cases per 100,000 individuals per year. The most common bacteria was Streptococcus pneumoniae, responsible for nearly half of the cases, and a significant portion of those were linked to vaccine-covered strains. This information matters because it shows how vaccines are impacting the types of bacterial meningitis seen in the community, guiding healthcare strategies. Who this helps: This helps patients and public health officials understand and manage bacterial meningitis risks.

Plain English
This study looked at the running habits of 227 runners, some of whom had knee surgery and some who hadn't, over four years. The research found that on average, men ran faster and longer distances than women, while runners with a history of knee surgery ran less frequently, shorter distances, and at a slower pace compared to those without surgery. These findings are important because they highlight how knee surgery can affect running performance and frequency, helping tailor training and recovery programs for different groups. Who this helps: This helps runners with knee issues and their healthcare providers.

Plain English
This study looked at how different ways of measuring a blood marker called phosphorylated tau 217 (p-tau217) can help in detecting amyloid beta positivity, which is related to conditions like Alzheimer’s disease. Researchers found that using an optimal cutoff specific to biological factors like kidney function and anemia significantly improved diagnostic accuracy—from 0.65 to 0.83 for kidney function, for example. Using these tailored measurement strategies not only helped in obtaining more accurate results but also made the process more cost-effective. Who this helps: This benefits patients being evaluated for Alzheimer’s and other cognitive disorders, as well as the doctors diagnosing them.

Plain English
This study focused on improving how emergency medicine residents learn to interpret electrocardiograms (ECGs), which are essential for diagnosing heart conditions. The researchers created a new educational program that included weekly emails with case studies, which boosted residents' test scores from an average of 70% to 82% and increased their pass rate from 58% to 92%. This improvement is important because it makes sure that residents have a standardized and comprehensive understanding of ECGs, which is crucial for their future work in emergency medicine. Who this helps: This helps emergency medicine residents and ultimately benefits their patients by enhancing the quality of care they provide.

Plain English
This study looked at a blood test that measures the level of a specific protein called p-tau217 to see if it can effectively indicate the stages of Alzheimer's disease, which are usually identified through PET scans. Researchers found that the blood test performed very well, with scores indicating strong accuracy—over 96% for early stages and over 92% for intermediate stages. This is important because it could provide a more accessible way to determine the right patients for treatment, without relying solely on expensive and limited PET scans. Who this helps: This benefits patients with Alzheimer’s disease and their doctors by providing an easier way to assess disease progression.

Plain English
This study looked at how different Alzheimer’s disease biomarkers in the blood and brain relate to changes in thinking skills over time. Researchers found that plasma p-tau217 levels were strongly linked to cognitive decline, explaining 16% of the variability in thinking skills at the Mayo Clinic and 64% in another group, highlighting its importance as a marker for disease progression. Understanding these relationships helps improve predictions about Alzheimer’s progression, which is crucial for better patient management. Who this helps: This benefits patients and doctors by providing insights into Alzheimer’s disease progression.

Plain English
This study looked at how well peripheral nerve stimulation (PNS) works for reducing pain in patients with chronic pain over two years. It found that patients experienced a significant drop in pain levels—about 3 points on a scale of 0 to 10—one year after receiving the treatment, and both temporary and permanent PNS provided similar pain relief. However, there was no reduction in the use of opioid pain medications during this time. Who this helps: This benefits patients with chronic pain seeking alternative treatments to manage their pain.

Plain English
This study looked at how blood cells are produced and maintained in the body, focusing on healthy mice. Researchers discovered that the number and behavior of different blood cell types can change significantly and unpredictably, sometimes in sync, and they found that these changes could shift from chaotic patterns to more regular ones as conditions like lymphoma develop. Understanding these patterns is important because it helps explain how blood cell production works and how diseases can alter this process. Who this helps: This helps doctors and researchers studying blood disorders and cancer.

Plain English
This research paper looks at how religion and spirituality (R/S) can positively affect people's physical and mental health. It highlights the need for healthcare providers to find ways to incorporate R/S into lifestyle medicine practices, as these factors can lead to better health outcomes and improved patient care. The authors encourage doctors to adapt their health recommendations to align with individual beliefs, fostering a more supportive approach to treatment. Who this helps: This helps patients looking for holistic care that respects their spiritual beliefs.

Plain English
This study examined how a blood test can assist doctors in diagnosing Alzheimer's disease and deciding on treatment for patients with memory problems. Among 203 patients aged 74 on average, the test accurately changed how doctors assessed Alzheimer's certainty or treatment plans 75% of the time. This is significant because it allows for better-targeted treatments and helps identify patients who might not have Alzheimer's, thus improving overall patient care. Who this helps: This helps patients with cognitive issues and their doctors in making more informed decisions.

Plain English
This study looked at how certain blood markers connected to Alzheimer's disease can predict changes in brain scans that show amyloid buildup in people who initially show no signs of the disease. Researchers found that higher levels of a protein called phosphorylated tau 217 in the blood significantly increased the chances (by 1.38 times) of these individuals progressing to abnormal amyloid levels. This is important because it suggests that measuring these blood markers could help identify people at greater risk for Alzheimer's, allowing for earlier and potentially preventative treatments. Who this helps: This helps patients who are at risk of developing Alzheimer's disease.

Plain English
This study looked at how the heart rate varies in dogs with Chagas disease to see if it can show problems with their nervous system and heart. Out of 112 dogs tested, 63% had irregular heart rate patterns, and symptomatic dogs had more heart rhythm issues than those who were asymptomatic. The results suggest that monitoring heart rate variation could help detect heart and nervous system problems early, even in dogs that don’t show symptoms yet. Who this helps: This helps veterinarians and dog owners detect early heart issues in dogs with Chagas disease.

Plain English
This study looked at blood tests to see if they can detect early signs of Alzheimer's disease in people who haven't yet developed dementia. Researchers found that two specific blood markers, %p-tau217 and the APS2 score, were very accurate—over 93%—at identifying the toxic proteins related to Alzheimer's in the brain. This is important because it means we can catch Alzheimer's earlier, which may help with treatment and clinical trials, and it can also lower costs of brain imaging by up to 45%. Who this helps: Patients at risk for Alzheimer's and their doctors.

Plain English
Researchers studied glioblastoma (GBM), a type of brain cancer, focusing on how tumors are organized and how cancer cells interact with each other in different areas of the tumor. They found that the structure of the tumor varies from the center to the edge, with different types of cells communicating in complex ways. For instance, they discovered that T cells, which help the immune system fight cancer, often cluster with other immune cells in blood vessel areas, which might help the tumor avoid being attacked by the immune system. This matters because understanding these interactions can lead to new treatments that target how cells communicate in the tumor, potentially improving care for patients with GBM. Who this helps: Patients with glioblastoma.

Plain English
This study looked at how the stiffness of a 3D gel affects the growth and development of blood vessel cells made from human stem cells. Researchers found that a medium stiffness level (551 Pa) helped cells mature but did not lead to the best blood vessel networks. On the other hand, softer gel (190 Pa) allowed for better connections between blood vessels, indicating that both the softness of the material and how cells move can influence blood vessel development. Who this helps: This research benefits patients needing improved tissue engineering and regenerative therapies.

Plain English
This study looked at the effectiveness of a blood test called PrecivityAD2, which helps determine if someone with cognitive issues has amyloid plaques in their brain, a hallmark of Alzheimer's disease. The results showed that 54% of participants with cognitive impairment tested positive for amyloid plaques using this blood test, and it accurately identified these plaques 91% of the time, with high sensitivity (90%) and specificity (92%). This is important because it provides a reliable way for doctors to confirm the presence of brain amyloid pathology, which can guide treatment decisions for patients with memory problems. Who this helps: This helps patients with cognitive impairment and their doctors in making informed decisions about diagnosis and treatment.

Plain English
This study looked at how certain markers in the blood related to Alzheimer's disease can predict the transition from being cognitively unimpaired to developing mild cognitive impairment (MCI). Researchers found that higher levels of specific markers, particularly %p-tau217, were linked to a greater risk of developing MCI, with hazard ratios of 1.49 for one group and 1.72 for another. This is important because it helps identify individuals at risk for cognitive decline and could lead to earlier interventions or treatments. Who this helps: This helps patients at risk for cognitive decline and their doctors in planning preventive care.

Plain English
Researchers tested the PrecivityAD2 blood test, which measures a score called the Amyloid Probability Score 2 (APS2), to see how well it identifies a type of brain damage linked to memory problems. They found that 54% of the people tested showed a positive result for amyloid, and the test had an accuracy of 91%, meaning it correctly identified the condition most of the time. This study is important because a reliable blood test can help diagnose brain issues earlier and more easily in people who have cognitive impairment. Who this helps: This benefits patients with memory problems and their doctors, as it provides a simpler way to diagnose brain amyloid pathology.

Plain English
This study looked at how spirituality and religiosity affect suicidal thoughts and behaviors in adolescents, analyzing 61 research papers that included over 340,000 young people. The researchers found that nearly 67% of the studies showed that being religious or spiritual is linked to a lower risk of suicidal thoughts and actions. This is important because it suggests that encouraging spirituality could help protect young people from suicide. Who this helps: This helps adolescents, particularly those at risk, as well as the doctors and caregivers who support them.

Plain English
This study looked at how well esketamine treats patients with treatment-resistant depression (TRD) who did not improve with electroconvulsive therapy (ECT). Out of four patients treated, three showed significant improvement, but only one was able to use esketamine successfully long-term due to side effects. These findings are important because they suggest that esketamine may still help some patients who have run out of other treatment options. Who this helps: This helps patients with treatment-resistant depression, especially those who've not responded to standard therapies.

Plain English
Researchers studied how well memory care specialists adopted a new blood test for Alzheimer's disease called PrecivityAD2. They found that healthcare providers rated the test extremely positively, giving an average acceptance score of 9.6 out of 10, and a high satisfaction score of 75 out of 100, indicating it is a valuable tool for helping make decisions about patient care. This research shows that the blood test is likely to improve the way doctors assess patients with memory issues, making it easier to personalize their treatment plans. Who this helps: This helps doctors and patients experiencing cognitive symptoms.

Plain English
This study looked at a new way to analyze the structure of proteins using a technique called isotope reverse-labeled FTIR spectroscopy. Researchers found that by labeling specific parts of a protein with isotopes, they could identify the structure of individual amino acids rather than just the overall protein structure. This method was low-cost (only a few dollars per sample) and provided detailed information that matched well with what was previously known from crystal structures. Who this helps: This benefits researchers studying protein structures, which is important for drug development and understanding biological functions.

Plain English
This study looked at how different parts of birds' heads, like their beaks and brains, have changed together over time. The researchers found that changes in one feature, like the size of the eyes or the type of jaw muscles, often relate closely to changes in other features, showing that these traits evolve in a connected way. This matters because it helps us understand how birds have developed their unique characteristics, revealing that their evolution involves complex relationships between various physical traits. Who this helps: This helps researchers studying bird evolution and provides insights that could benefit conservation efforts.

Plain English
This study looked at neurosurgery residency programs in the U.S. during the 2022-2023 academic year to understand how these programs are structured and how that affects the productivity of their trainees. It found that each program had a median of 2 resident positions per year and provided an annual academic stipend of $1,000, which significantly influenced the residents' academic output. Understanding these dynamics is important because it helps to ensure that neurosurgery programs effectively train skilled professionals who can provide better care in the future. Who this helps: This helps future neurosurgeons and the patients who will rely on their expertise.

Plain English
This study examined blood markers related to Alzheimer's disease to see if they could help identify individuals at risk before symptoms appear. Researchers found that a specific blood test that measures ratios of tau and amyloid beta proteins significantly improved accuracy in detecting early signs of Alzheimer's, achieving an accuracy score of 0.95 when combining the most effective markers. This is important because early detection can lead to timely treatment and participation in clinical trials for potential therapies. Who this helps: Patients at risk for Alzheimer's disease.

Plain English
This study looked at how sleep duration and daytime sleepiness affect brain health and thinking skills in middle-aged and older African Americans who are not experiencing cognitive problems. The researchers found that participants averaged 6.4 hours of sleep per night, which is less than the recommended amount, and 22.4% reported feeling excessively sleepy during the day. While they did not find a direct link between sleep patterns and certain brain markers related to dementia, they observed that poorer sleep was associated with worse cognitive performance, highlighting the need for further research into how sleep affects brain health, especially in groups at higher risk for dementia. Who this helps: This helps patients and healthcare providers focused on cognitive health in African American communities.

Plain English
This paper studied how the U.S. Ryan White HIV/AIDS Program (RWHAP) and the President’s Emergency Plan for AIDS Relief (PEPFAR) can learn from each other to improve their efforts in fighting HIV/AIDS. The findings highlighted that by sharing successful strategies and best practices, both programs could better support HIV treatment and response efforts, ultimately improving health services in both low- and middle-income countries and the U.S. Specifically, they emphasized the need for ongoing collaboration, innovation, and technology to effectively tackle the epidemic. Who this helps: This benefits patients with HIV/AIDS, healthcare providers, and public health organizations.

Plain English
This study looked at a new, less invasive surgical approach to remove and revise certain implants used in the sacroiliac joint (SIJ) for patients with ongoing pain. The researchers treated a 72-year-old woman who had recurring back pain from an earlier surgery, successfully removing her troublesome triangular implant and replacing it using a combination of advanced navigation technology and minimally invasive techniques. This method could make such surgeries easier and safer, potentially leading to better outcomes for patients experiencing similar complications. Who this helps: This helps patients suffering from persistent back pain after SIJ surgery and the doctors performing their care.

Plain English
Researchers studied a new blood test called PrecivityAD2 to see how well it can identify the presence of amyloid plaques in the brain, which are linked to Alzheimer's disease. They tested blood samples from 583 individuals suspected of having Alzheimer's and found that the test successfully matched results from brain imaging in 88% of cases, with a performance score of 0.94, indicating high accuracy. This research is important because it provides a reliable way for doctors to diagnose Alzheimer's disease, particularly as new treatments become available that require confirmation of amyloid presence. Who this helps: This helps patients and doctors by providing a more accurate method for diagnosing Alzheimer's disease.

Plain English
This study tested a drug called Posiphen in patients with early Alzheimer's Disease to see if it is safe and how it affects a protein linked to the disease. The trial involved 19 participants who took either Posiphen or a placebo for 21-23 days. While Posiphen was found to be safe and well-tolerated, it did not significantly change levels of amyloid beta proteins or improve cognitive function compared to placebo. Who this helps: This research helps patients with early Alzheimer's Disease and their doctors.

Plain English
This study looked at how different racial and ethnic groups were eligible for a trial testing treatments for Alzheimer's disease based on a specific blood test. Out of 4,905 participants, fewer individuals from underrepresented groups were eligible based on their plasma results—only 13.3% of Hispanic Black participants qualified, compared to 38.9% of non-Hispanic White participants. However, once they qualified through the blood tests, all groups had similar eligibility for further brain scans. This matters because it highlights the need for more inclusive criteria so treatments for Alzheimer's are available to everyone, regardless of race or ethnicity. Who this helps: This helps patients, particularly those from underrepresented racial and ethnic backgrounds.

Plain English
This study looked at a specific brain condition called Posterior Reversible Encephalopathy Syndrome (PRES) that can occur in women after giving birth, particularly when they have complications like eclampsia. The case of a woman in her late 20s was presented, who experienced severe agitation and paranoia after developing eclampsia during pregnancy; imaging tests confirmed she had PRES, but her symptoms improved with the right treatment. The study highlights the need for doctors to work together to distinguish between different mental health issues that can arise in new mothers, which is crucial for providing the right care. Who this helps: This helps new mothers experiencing severe mental health symptoms after childbirth.

Plain English
This study looked at a drug called Posiphen to see if it is safe and how it affects the levels of a protein linked to Alzheimer's disease in people with early symptoms of the illness. Out of 19 participants, those who took Posiphen reported it was safe, but the study did not find clear changes in Alzheimer's-related proteins or cognitive performance after three weeks of treatment. This research is important because it adds to the understanding of how new Alzheimer’s treatments might work, even though the small number of participants limits the findings. Who this helps: Patients with early Alzheimer's disease and their doctors.

Plain English
This study looked at a blood test designed to help diagnose Alzheimer’s disease (AD) in patients showing cognitive symptoms. Researchers tested the blood samples from 1,213 patients in two groups (primary care and secondary care) and found that about half of them had signs of AD. The blood test showed high accuracy, with a 91% chance of correctly identifying those with AD in the secondary care group and 90% in the primary care group, which is significantly better than the usual methods used by doctors. Who this helps: This benefits patients suspected of having Alzheimer’s disease by providing a quicker and more accurate way to diagnose the condition.

Plain English
This study looked at the effectiveness of various commercial treatments for allergies caused by house dust mites. Researchers reviewed 56 clinical trials involving over 14,600 patients and found that two specific sublingual tablets (ALK 12 and ALK 6) showed strong evidence for treating both allergic rhinitis and asthma. This information is important for guiding doctors in choosing the right allergy treatments for patients. Who this helps: This helps patients suffering from allergies and asthma triggered by house dust mites.

Plain English
This study focused on hallux rigidus, a condition that causes stiffness and pain in the big toe. Experts reviewed existing information and created 24 key statements about the best ways to understand and treat this condition. These findings are important because they provide clear guidance for doctors, helping them make better decisions for their patients. Who this helps: Patients with hallux rigidus and their doctors.

Plain English
This research examined a new blood test called PrecivityAD2, which measures specific proteins in the blood to help diagnose Alzheimer's disease. The test accurately identifies the presence of brain amyloid plaques and tau tangles, essential indicators of Alzheimer’s. Findings show that the test is reliable and maintains its accuracy under various conditions, with only 3.5% of results changing from positive to negative or vice versa, indicating strong consistency. Who this helps: This benefits patients aged 55 and older who have signs of mild cognitive impairment or dementia.

Plain English
This study looked at a molecule called D-cysteine in the pancreas and how it affects insulin secretion. Researchers found that mice with higher levels of D-cysteine produced 6 to 10 times more insulin than usual, which is important for managing blood sugar levels. This matters because it could lead to new treatments for diabetes, especially in how insulin is regulated during glucose stimulation. Who this helps: Patients with diabetes.

Plain English
This research paper examines how artificial intelligence (AI) can be used to improve the study of evolutionary morphology, which looks at how organisms change over time. The authors highlight that, while traditional AI techniques have been used for years, new deep learning methods can analyze large sets of data about physical traits much more efficiently. They believe this could significantly advance our understanding of evolution, especially as more digital databases become available. Who this helps: This benefits researchers and scientists studying evolutionary biology and related fields.

Plain English
This study looked at how to better identify dangerous pathogens that could threaten agricultural health and safety in the U.S. The researchers used two methods to evaluate 41 pathogens based on criteria like their threat level, economic impact, and risk of being used in bioterrorism. They found that both methods reached similar conclusions, supporting the need for expert input to accurately assess which pathogens should be designated as high-risk. Who this helps: This benefits agricultural regulators and farmers by ensuring safer practices against potentially harmful biological agents.

Plain English
This study looked at how a blood test called the PrecivityAD test helps doctors evaluate patients for Alzheimer's disease and other causes of memory problems. They found that 95% of the time, doctors selected the right patients for the test. The results showed that after receiving a low amyloid probability score, doctors lowered their likelihood of diagnosing Alzheimer's from 58% to 23%, while for those with a high score, the probability increased from 71% to 89%. This is important because it helps doctors make better treatment decisions and improves patient management as new Alzheimer's treatments become available. Who this helps: This helps patients and their doctors by providing clearer insights for diagnosis and treatment options.

Plain English
This study examined a rare complication that can occur after a celiac plexus block, a procedure used to relieve severe abdominal pain. A 67-year-old man undergoing this treatment for cancer-related pain developed sudden weakness in his legs after the procedure, which was likely caused by a temporary issue with blood flow in his spinal artery. Unfortunately, he later faced serious complications that led to his passing, highlighting the need for doctors to carefully discuss the risks of this procedure, especially in patients with serious illnesses. Who this helps: Patients undergoing celiac plexus blocks and their doctors.

Plain English
This study focused on understanding how certain biological markers and variations in cognitive performance relate to brain health in Black Americans, specifically in the context of Alzheimer's disease. Researchers looked at 257 Black participants and measured blood levels of amyloid beta (Aβ42/40) and the consistency of their cognitive test scores over time. They found that while the amyloid levels weren't connected to initial cognitive performance, lower levels were linked to faster cognitive decline later on. This research is important because it highlights the need for more inclusive Alzheimer's studies, helping to ensure better diagnosis and treatment for historically overlooked groups. Who this helps: This benefits Black Americans worried about Alzheimer's and the doctors treating them.

Plain English
This study looked at how to improve the USDA's process for reviewing and updating a list of dangerous biological agents that can harm important crops. Using a combination of decision-making techniques, researchers evaluated 16 pathogens based on 9 criteria and found that while most harmful agents ranked high, some currently listed agents might need reevaluation due to their actual threat levels. This is important because it helps ensure that resources are focused on the most relevant agricultural threats and can improve safety measures against bioterrorism. Who this helps: This helps farmers, agricultural regulators, and policymakers.

Plain English
This study looked at a rare condition called pseudocyesis, where a person feels and shows signs of being pregnant even though they are not. It reports on a homeless woman with a severe mental health issue who experienced symptoms like a swollen abdomen and cramping, despite not being pregnant. The findings highlight the need for careful and compassionate treatment of patients like her, as their symptoms are very real and can complicate their care. Who this helps: This helps patients experiencing pseudocyesis and the healthcare providers caring for them.

Plain English
This study looked at the effects of anti-CD20 antibody therapy, specifically ocrelizumab and rituximab, in women with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) who were breastfeeding after giving birth. Researchers found that the amount of these drugs in breastmilk was very low (with ocrelizumab at 0.08 micrograms per milliliter and rituximab at 0.03 micrograms per milliliter), and breastfeeding did not impact infant growth or development after 8 to 12 months. This is important because it shows that these treatments are safe for postpartum mothers and their infants, allowing women to manage their conditions while breastfeeding. Who this helps: This helps postpartum women with MS and NMOSD who want to continue breastfeeding while managing their health.